TITLE

Methylphenidate-Induced Neuropathology in the Developing Rat Brain: Implications for Humans

AUTHOR(S)
Leo, Jonathan
PUB. DATE
July 2005
SOURCE
Ethical Human Psychology & Psychiatry;Summer2005, Vol. 7 Issue 2, p107
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
The author expresses his opinion regarding the study of the implications for humans of methylphenidate-induced neuropathology in the developing rat brain. The study was conducted by William Carlezon and his colleagues at Harvard Medical School in Boston, Massachusetts. It was found that Ritalin has harmful long-term effects on the developing rat brain by having an increased risk of depression in adulthood. The American College of Neuropsychopharmacology (ACNP) said a proper diagnosis is still needed although Ritalin is effective in ADHD treatment.
ACCESSION #
25919046

 

Related Articles

  • Methylphenidate.  // Reactions Weekly;03/23/2013, Issue 1445, p28 

    The article presents a case study of the development of appetite suppression and weight loss in a female adolescent while being treated with methylphenidate for attention deficit hyperactivity disorder (ADHD).

  • Methylphenidate overdose.  // Reactions Weekly;4/25/2009, Issue 1249, p32 

    The article describes a case report of a 13-year-old patient who developed psychosis while he was receiving methylphenidate for attention deficit hyperactivity disorder (ADHD). Information is given on the medical history of the patient. It also details the dosage of the drug taken by the...

  • Methylphenidate.  // Reactions Weekly;2/14/2009, Issue 1239, p23 

    The article describes the case of a 5-year-old boy with attention-deficit hyperactivity disorder (ADHD) who developed periods of hypertalkativity after the administration of methylphenidate. After starting treatment with methylphenidate, his mother and teacher both reported hypertalkativity....

  • Adrafinil/paroxetine interaction.  // Reactions Weekly;10/3/2009, Issue 1272, p6 

    The article discusses a case report of a 35-year-old man with depressive disorder and attention-deficit hyperactivity disorder who developed stimulant syndrome after being treated with adrafinil 900 milligrams (mg)/day and paroxetine 40 mg/day. After stopping paroxetine on his own accord, the...

  • Buspirone Versus Methylphenidate in the Treatment of Attention Deficit Hyperactivity Disorder: A Double-Blind and Randomized Trial. Davari-Ashtiani, Rozita; Shahrbabaki, Mahin Eslami; Razjouyan, Katayoon; Amini, Homayoun; Mazhabdar, Homa // Child Psychiatry & Human Development;Dec2010, Vol. 41 Issue 6, p641 

    The efficacy and side effects of buspirone compared with methylphenidate (MPH) in the treatment of children with attention-deficit/hyperactivity disorder (ADHD). A total of 34 children with ADHD as defined by DSM-IV-TR were randomized to buspirone or methylphenidate dosed on weight-adjusted...

  • ADHD.  // Latitudes Online;6/30/2006, Vol. 7 Issue 3, p8 

    The article reports that increased level of smoking is one of the concerns regarding the use of stimulant medications, like Ritalin, in treating attention-deficit hyperactivity disorder.

  • Medicating Ourselves to Death. Priesnitz, Wendy // Natural Life;May/Jun2006, Issue 109, p2 

    The article comments on the issues concerning the use of Ritalin and similar drugs for the treatment of children with Attention-Deficit Hyperactive Disorder in the U.S. and Canada. Ritalin and other similar drugs are widely used even if there has not been much safety research done on these...

  • Methylphenidate.  // Reactions Weekly;8/5/2006, Issue 1113, p14 

    The article discusses research being done on the side effects of methylphenidate used for the treatment of attention-deficit hyperactivity disorder. It references a study by R. G. Ross published in the July 2006 issue of the "American Journal of Psychiatry." The association of methylphenidate...

  • Methylphenidate.  // Reactions Weekly;4/4/2009, Issue 1246, p26 

    The article describes the cases of a girl and three boys aged 8 to 14 years who developed psychosis while being treated with methylphenidate for attention-deficit hyperactivity disorder (ADHD). It references a study by S. Shibib and N. Chalhoub et al, published in a 2009 issue of the journal...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics